Sign In
Buy ONPH
$0.0700
+0.0150 (+27.27%)
At Close: Jul 31, 2026
Oncology Pharma Research and Vision
01:02pm, Tuesday, 30'th Nov 2021 InvestorsHub
San Francisco, CA -- November 30, 2021 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is a pioneering oncology company dedicated to providing the financing and the tools to license, develop, manufacture, and commercialize therapeutics. The Company has assembled a team of executives and advisors with proven multi-disciplinary expertise in the fields of oncology and therapeutics with leadership to identify, n...
Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing
09:57am, Friday, 15'th Oct 2021
SAN FRANCISCO, CA / ACCESSWIRE / October 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Pursuant to previously announced press release, Oncology Pharma, Inc. (the "Company") has retained the services
SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH). In keeping with management's commitment to continue implementation of Oncology Pharma's ("the Company") cap
Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives
08:00am, Monday, 23'rd Aug 2021
SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH) defines its objective and strategy for recently signed Co-Development deal. The primary goal of the Co-Developm
Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc.
07:30am, Thursday, 19'th Aug 2021
SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) With much anticipation, Oncology Pharma, Inc. has finalized a Co-Development Agreement with NanoSmart Pharmaceut
Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP
07:30am, Tuesday, 20'th Jul 2021
SAN FRANCISCO, CA / ACCESSWIRE / July 20, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is laying out and taking necessary steps to move its licensed IP forward. Fr
Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase
08:00am, Wednesday, 30'th Jun 2021
SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is developing a program to establish the use of its license utilizing NR2F6
Shares of This Biotech Stock Could Jump 437%
02:04am, Wednesday, 23'rd Jun 2021
Published by: Tim Kraimer Oncology Pharma, Inc. (Symbol: ONPH) is a San Francisco-based biotech company that has been making one blockbuster announcement after the next. These announcements have sent
Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer
08:00am, Tuesday, 18'th May 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is pursuing, through its licensing arrangements, the development of a small
This Biotech Stock Could Jump +500%
09:35am, Friday, 14'th May 2021
Published by: Nick Martin Oncology Pharma, Inc. (Symbol: ONPH) is a San Francisco-based biotech company that has been making one blockbuster announcement after the next. These announcements have se
Oncology Pharma, Inc. Has Submitted Its Initial Application to List the Company on the Capital Markets Tier of the NASDAQ Exchange
10:10pm, Wednesday, 12'th May 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 12, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") has submitted its initial application to the NASDAQ to begin the process o
Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer
08:00am, Friday, 07'th May 2021
SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) ONPH has entered into a licensing agreement with Regen BioPharma, Inc. for a technology utilizing small molecules
SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is moving ahead with advancing its efforts with Ribera Solutions' Conect2M
Oncology Pharma, Inc. Addresses Pancreatic Cancer, the Need for an Effective Therapy and the Potential of mRNA Technology
08:00am, Wednesday, 14'th Apr 2021
SAN FRANCISCO, CA / ACCESSWIRE / April 14, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) On April 7, 2021 Oncology Pharma, Inc. (the "Company") reported that it had been granted an exclusive worldwide
RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today
03:00pm, Thursday, 08'th Apr 2021
Here's why RGBP stock is seeing massive gains today, following an annoucnement investors seem to be very bullish on. The post RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today appeare
